Report Feature
The future of the global metabolomics market looks promising with opportunities in various appliations, such as biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, and personalized medicine. The global metabolomics market is expected to grow with a CAGR of 13%-15% from 2020 to 2025. The major drivers for this market are increasing research and development activities in pharmaceutical and biotechnology and increasing prevalence of chronic diseases.
Emerging trends, which have a direct impact on the dynamics of the industry, include growing adoption of HPLC and UPLC technique for its most versatile separation method.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global metabolomics market report, please download the report brochure.
In this market, metabolomics instruments is the largest product and service of metabolomics, whereas biomarker discovery is the largest application. Growth in various segments of the metabolomics market are given below:
The study includes trends and forecast for the global metabolomics market by product and service, application, indication, and region as follows:
By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:
- Metabolomics Instruments
- Separation Tools
- Detection Tools
- Metabolomics Bioinformatics Tools and Services
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Biomarker Discovery
- Drug Discovery
- Toxicology Testing
- Nutrigenomics
- Functional Genomics
- Personalized Medicine
- Other Applications
By Indication [Value ($ Million) shipment analysis for 2014 – 2025]:
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Inborn Errors of Metabolism
- Other Indications
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- German
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Some of the metabolomics companies profiled in this report include Agilent Technologies, Bio- Rad Laboratories, Bruker Corporation, Danaher, Thermo Fisher Scientific, Waters Corporation, Shimadzu Corporation, LECO Corporation, Biocrates Life Sciences, and Metabolon.
Lucintel forecasts that metabolomics instruments will remain the largest product and service segment over the forecast period, as they are mostly used in research activities.
Within this market, biomarker discovery will remain the largest application segment over the forecast period due to rising prevalance of chronic diseases, such as cancer and diabetes, and increasing acceptance of cancer diagnostic tests.
North America will remain the largest region over the forecast period due to high per capita healthcare expenditure and increasing adoption of healthcare technology.
|
Features of the Global Metabolomics Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global metabolomics market by product and service (metabolomics instruments, separation tools and detection tools ) and metabolomics bioinformatics tools and services), application (biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and other applications), indication (cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and other indications), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global metabolomics market? Q.5 What are the business risks and threats to the global metabolomics market? Q.6 What are the emerging trends in this metabolomics market and the reasons behind them? Q.7 What are some changing demands of customers in this metabolomics market? Q.8 What are the new developments in this metabolomics market? Which companies are leading these developments? Q.9 Who are the major players in this metabolomics market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this metabolomics market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global metabolomics market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product and Service (Metabolomics Instruments, Separation Tools and Detection Tools ) and Metabolomics Bioinformatics Tools and Services), Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Other Applications), and Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Other Indications) |
|
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Metabolomics Market
4.1 Global Metabolomics Market by Region
4.2.1 Market by Product and Service: Metabolomics Instruments (Separation Tools and Detection Tools) and Metabolomics Bioinformatics Tools and Services
4.2.2 Market by Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Other Applications
4.2.3 Market by Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Other Indications
4.2.4 The United States Metabolomics Market
4.2.5 The Canadian Metabolomics Market
4.2.6 The Mexican Metabolomics Market
4.3.1 Market by Product and Service: Metabolomics Instruments (Separation Tools and Detection Tools) and Metabolomics Bioinformatics Tools and Services
4.3.2 Market by Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Other Applications
4.3.3 Market by Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Other Indications
4.3.4 The Metabolomics Market of United Kingdom
4.3.5 The Spanish Metabolomics Market
4.3.6 The German Metabolomics Market
4.3.7 The French Metabolomics Market
4.4.1 Market by Product and Service: Metabolomics Instruments (Separation Tools and Detection Tools) and Metabolomics Bioinformatics Tools and Services
4.4.2 Market by Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Other Applications
4.4.3 Market by Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Other Indications
4.4.4 The Chinese Metabolomics Market
4.4.5 The Indian Metabolomics Market
4.4.6 The Japanese Metabolomics Market
4.5.1 Market by Product and Service: Metabolomics Instruments (Separation Tools and Detection Tools) and Metabolomics Bioinformatics Tools and Services
4.5.2 Market by Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Other Applications
4.5.3 Market by Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Other Indications
4.5.4 Brazilian Metabolomics Market
7.1.1 Growth Opportunities for the Global Metabolomics Market by Product and Service
7.1.2 Growth Opportunities for the Global Metabolomics Market by Application
7.1.3 Growth Opportunities for the Global Metabolomics Market by Indication
7.1.4 Growth Opportunities for the Global Metabolomics Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
